3 results
Approved WMOCompleted
The primary efficacy objective of the study is:* to evaluate whether rivaroxaban added to ASA is superior to ASA alone in reducingthe risk of major thrombotic vascular events (defined as MI, ischemic stroke, CVdeath, ALI, and major amputation of a…
Approved WMORecruiting
The objective of this study is to evaluate the safety and efficacy of the AccuCinch Ventricular Restoration System in patients with symptomaticheart failure with reduced ejection fraction (HFrEF).
Approved WMORecruiting
Compare neurophysiological biomarkers with symptom control and stimulation parameters to improve stimulation settings for individual patients with Parkinson*s disease, tremor syndromes and dystonia.